HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Martin Selected Research

Vemurafenib

5/2020Corrigendum to "Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells" [Biochem. Pharmacol. 93 (3) (2015) 290-304].
2/2015Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Martin Research Topics

Disease

19Type 2 Diabetes Mellitus (MODY)
07/2017 - 12/2003
17Scrapie
04/2017 - 01/2000
16Infections
01/2015 - 05/2000
13Neoplasms (Cancer)
02/2020 - 07/2000
7Inflammation (Inflammations)
02/2019 - 08/2005
7Obesity
12/2015 - 08/2005
6Prion Diseases (Transmissible Spongiform Encephalopathies)
04/2017 - 04/2003
6Bovine Spongiform Encephalopathy (Mad Cow Disease)
01/2015 - 01/2006
6Cardiovascular Diseases (Cardiovascular Disease)
02/2013 - 08/2001
5Wounds and Injuries (Trauma)
03/2021 - 04/2001
5Melanoma (Melanoma, Malignant)
05/2020 - 01/2005
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2009 - 09/2001
4Glucose Intolerance
01/2018 - 06/2002
4Stroke (Strokes)
12/2012 - 05/2003
4Myocardial Infarction
10/2008 - 05/2003
3Hemorrhage
03/2017 - 01/2006
3Neuroblastoma
01/2017 - 07/2013
3Glioblastoma (Glioblastoma Multiforme)
04/2016 - 04/2001
3Body Weight (Weight, Body)
04/2014 - 11/2000
3Weight Loss (Weight Reduction)
03/2014 - 12/2003
3Hypertension (High Blood Pressure)
10/2013 - 08/2001
3Insulin Resistance
02/2013 - 05/2000
3Necrosis
04/2008 - 12/2001
3Blindness (Hysterical Blindness)
09/2007 - 05/2003
3Tuberculosis (Tuberculoses)
01/2006 - 09/2002
3Tetanus
08/2005 - 04/2001
3Thrombosis (Thrombus)
12/2002 - 06/2001
3Dehydration (Water Stress)
10/2001 - 04/2000
2Ulcerative Colitis
02/2019 - 03/2017
2Hypocalcemia
01/2019 - 11/2009
2Asthma (Bronchial Asthma)
01/2019 - 02/2014
2Hypersensitivity (Allergy)
01/2018 - 01/2018
2Neoplasm Metastasis (Metastasis)
02/2017 - 07/2000
2Glioma (Gliomas)
04/2016 - 07/2000
2Morbid Obesity
03/2014 - 10/2013
2Rhinitis
02/2014 - 01/2014
2Conjunctivitis
02/2014 - 01/2014
2Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
06/2013 - 01/2010
2Bites and Stings (Sting)
11/2012 - 10/2004
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2012 - 04/2007
2Tendinopathy (Tendonitis)
05/2010 - 01/2006
2Pain (Aches)
09/2007 - 05/2005
2Hypoxia (Hypoxemia)
08/2007 - 03/2001
2Cystic Fibrosis (Mucoviscidosis)
07/2006 - 02/2000
2Fibrosis (Cirrhosis)
07/2006 - 11/2001
2Atherosclerosis
05/2006 - 05/2006

Drug/Important Bio-Agent (IBA)

18Prion ProteinsIBA
04/2017 - 10/2000
12Proteins (Proteins, Gene)FDA Link
04/2016 - 07/2000
11Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugateIBA
01/2015 - 01/2002
8Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2001
6Insulin (Novolin)FDA Link
07/2017 - 05/2000
6Blood Glucose (Blood Sugar)IBA
12/2012 - 02/2006
6Interleukin-6 (Interleukin 6)IBA
03/2009 - 06/2002
6CytokinesIBA
04/2008 - 11/2004
5Biomarkers (Surrogate Marker)IBA
08/2013 - 08/2005
4AntibodiesIBA
11/2012 - 05/2000
4Peptides (Polypeptides)IBA
01/2006 - 08/2000
3Biological ProductsIBA
04/2017 - 02/2012
3Messenger RNA (mRNA)IBA
10/2015 - 05/2006
3CalciumIBA
03/2012 - 11/2009
3Peptide Hydrolases (Proteases)FDA Link
12/2009 - 05/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 06/2002
3ChemokinesIBA
05/2006 - 08/2005
3Amino AcidsFDA Link
04/2003 - 03/2001
3Anti-Bacterial Agents (Antibiotics)IBA
01/2003 - 03/2001
2Oxygen (Dioxygen)IBA
03/2021 - 03/2001
2ElementsIBA
07/2020 - 07/2000
2VemurafenibIBA
05/2020 - 02/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2020 - 02/2015
2Anti-Allergic Agents (Antiallergic Agents)IBA
01/2018 - 02/2014
2Small Interfering RNA (siRNA)IBA
01/2017 - 08/2015
2Apoptosis Regulatory ProteinsIBA
04/2016 - 04/2001
2CaspasesIBA
04/2016 - 02/2015
2AndrogensIBA
12/2015 - 03/2014
2Pharmaceutical PreparationsIBA
02/2015 - 02/2014
2Glutamine (L-Glutamine)FDA Link
01/2015 - 01/2014
2Codon (Codons)IBA
01/2015 - 10/2000
2Arginine (L-Arginine)FDA Link
01/2015 - 01/2014
2Valine (L-Valine)FDA Link
01/2014 - 10/2000
2Insulin-Like Growth Factor I (IGF-1)IBA
10/2013 - 02/2013
2AdiponectinIBA
10/2013 - 02/2013
24-O-carboxymethylascochlorinIBA
07/2012 - 10/2002
2LipidsIBA
07/2012 - 08/2001
2C-Reactive ProteinIBA
03/2009 - 04/2005
2LipopolysaccharidesIBA
02/2009 - 04/2008
2PrPSc ProteinsIBA
05/2006 - 01/2006
2SolutionsIBA
05/2006 - 07/2000

Therapy/Procedure

26Therapeutics
11/2021 - 01/2000
6Drug Therapy (Chemotherapy)
08/2017 - 06/2002
5Transplantation
08/2017 - 07/2000
4Radiotherapy
02/2020 - 09/2008
3Stem Cell Transplantation
01/2019 - 01/2000
3Bariatric Surgery
03/2014 - 07/2012
3Operative Surgical Procedures
06/2013 - 04/2001
3Surgical Amputation (Amputations)
09/2007 - 05/2003
2Thyroidectomy
01/2019 - 11/2009
2Neck Dissection (Radical Neck Dissection)
01/2019 - 11/2009
2Aftercare (After-Treatment)
06/2015 - 05/2005
2Gastrectomy
03/2014 - 07/2012
2Liver Transplantation
07/2006 - 10/2002